专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08027719B2 Method and apparatus for delivering defibrillation shock therapy while reducing electrical dispersion due to ventricular conduction disorder 有权
标题翻译：用于递送除颤休克疗法同时减少由于心室传导障碍引起的电离散的方法和装置
公开(公告)号：US08027719B2
公开(公告)日：2011-09-27
申请号：US12051997
申请日：2008-03-20
申请人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
发明人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
IPC分类号： A61N1/00
CPC分类号： A61N1/3622 , A61N1/3627 , A61N1/3684 , A61N1/3962
摘要： A method and device for delivering defibrillation shock therapy in patients having an inter-ventricular conduction disorder is presented. Ventricular resynchronization therapy is employed to reduce the dispersion of ventricular depolarization which takes place due to the conduction disorder and reduces the safety margin of shocks delivered synchronously with ventricular beats. The method may be employed in the treatment of atrial or ventricular tachyarrhythmias.
摘要翻译：提出了一种用于在患有心室间传导障碍的患者中递送除颤休克疗法的方法和装置。采用心室再同步治疗来减少由于传导障碍引起的心室去极化的分散，降低与心室搏动同步传递的休克的安全余量。该方法可用于治疗心房或室性快速性心律失常。

2. 发明申请

US20080167692A1 METHOD AND APPARATUS FOR DELIVERING DEFIBRILLATION SHOCK THERAPY WHILE REDUCING ELECTRICAL DISPERSION DUE TO VENTRICULAR CONDUCTION DISORDER 有权
标题翻译：用于在减轻因静脉导管障碍引起的电解液的情况下提供减震手术的方法和装置
公开(公告)号：US20080167692A1
公开(公告)日：2008-07-10
申请号：US12051997
申请日：2008-03-20
申请人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
发明人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
IPC分类号： A61N1/362
CPC分类号： A61N1/3622 , A61N1/3627 , A61N1/3684 , A61N1/3962
摘要： A method and device for delivering defibrillation shock therapy in patients having an inter-ventricular conduction disorder is presented. Ventricular resynchronization therapy is employed to reduce the dispersion of ventricular depolarization which takes place due to the conduction disorder and reduces the safety margin of shocks delivered synchronously with ventricular beats. The method may be employed in the treatment of atrial or ventricular tachyarrhythmias.
摘要翻译：提出了一种用于在患有心室间传导障碍的患者中递送除颤休克疗法的方法和装置。采用心室再同步治疗来减少由于传导障碍引起的心室去极化的分散，降低与心室搏动同步传递的休克的安全余量。该方法可用于治疗心房或室性快速性心律失常。

3. 发明授权

US07349734B2 Method and apparatus for delivering defibrillation shock therapy while reducing electrical dispersion due to ventricular conduction disorder 失效
标题翻译：用于递送除颤休克疗法同时减少由于心室传导障碍引起的电离散的方法和装置
公开(公告)号：US07349734B2
公开(公告)日：2008-03-25
申请号：US10746856
申请日：2003-12-24
申请人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
发明人： Jeffrey E. Stahmann , Jesse W. Hartley , Steven D. Girouard
IPC分类号： A61N1/00
CPC分类号： A61N1/3622 , A61N1/3627 , A61N1/3684 , A61N1/3962
摘要： A method and device for delivering defibrillation shock therapy in patients having an inter-ventricular conduction disorder is presented. Ventricular resynchronization therapy is employed to reduce the dispersion of ventricular depolarization which takes place due to the conduction disorder and reduces the safety margin of shocks delivered synchronously with ventricular beats. The method may be employed in the treatment of atrial or ventricular tachyarrhythmias.
摘要翻译：提出了一种用于在患有心室间传导障碍的患者中递送除颤休克疗法的方法和装置。采用心室再同步治疗来减少由于传导障碍引起的心室去极化的分散，降低与心室搏动同步传递的休克的安全余量。该方法可用于治疗心房或室性快速性心律失常。

4. 发明授权

US09089275B2 Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance 有权
标题翻译：使用经胸阻塞时肺水肿检测的灵敏度和特异性
公开(公告)号：US09089275B2
公开(公告)日：2015-07-28
申请号：US11126723
申请日：2005-05-11
申请人： Jeffrey E. Stahmann , John Hatlestad , Jesse W. Hartley
发明人： Jeffrey E. Stahmann , John Hatlestad , Jesse W. Hartley
IPC分类号： A61B5/053
CPC分类号： A61B5/053 , A61B5/0537 , A61B5/4869 , A61M2230/40 , A61M2230/65 , A61N1/36521 , A61N1/37282
摘要： This patent document discusses, among other things, systems, devices, and methods for enhancing detection of pulmonary edema using, in addition to thoracic impedance, one or a combination of: physiologic information about a subject, at least one statistical parameter, a user-programmable detection level, at least one parameter associated with a previous pulmonary edema event, and patient symptom information about the subject. In one example, a (base) thoracic impedance threshold is modified to an adjusted thoracic impedance threshold. The adjusted thoracic impedance threshold provides an increased sensitivity of pulmonary edema detection as compared to the base thoracic impedance threshold. In another example, an alert is provided to a subject, a caregiver, or other user based on a pulmonary edema indication determined by the present systems, devices, and methods. In a further example, a therapy (provided to the subject) is adjusted or initiated in response to the pulmonary edema indication.
摘要翻译：该专利文献尤其涉及用于增强肺水肿检测的系统，装置和方法，除胸部阻抗之外，还包括以下之一或组合：关于受试者的生理信息，至少一个统计参数，可编程检测水平，与先前的肺水肿事件相关联的至少一个参数，以及关于受试者的患者症状信息。在一个示例中，（基底）胸部阻抗阈值被修改为经调整的胸部阻抗阈值。与基础胸廓阻抗阈值相比，经调整的胸廓阻抗阈值提供了肺水肿检测的灵敏度增加。在另一示例中，基于由本系统，设备和方法确定的肺水肿指示，向受检者，照顾者或其他用户提供警报。在另一个实例中，响应于肺水肿指示调整或启动治疗（提供给受试者）。

5. 发明授权

US08795189B2 System and method for determining pulmonary performance from transthoracic impedance measures 有权
标题翻译：用于确定经胸阻抗措施的肺功能的系统和方法
公开(公告)号：US08795189B2
公开(公告)日：2014-08-05
申请号：US12029422
申请日：2008-02-11
申请人： Quan Ni , Jesse W. Hartley , Kent Lee , Jeffrey E. Stahmann
发明人： Quan Ni , Jesse W. Hartley , Kent Lee , Jeffrey E. Stahmann
IPC分类号： A61B5/08
CPC分类号： A61B5/0809 , A61B5/0002 , A61B5/0535 , A61N1/36521 , G06F19/3418
摘要： A system and method for determining pulmonary performance from transthoracic impedance measures is provided. Transthoracic impedance measures collected by an implantable medical device are correlated to pulmonary functional measures. The pulmonary functional measures are grouped by respiratory pattern. Pulmonary performance is evaluated. Differences are determined by comparing the pulmonary functional measures for each respiratory pattern to the pulmonary functional measures for at least one previous respiratory pattern. A trend is identified from the differences. An alert is generated upon sufficient deviation of the trend from a threshold criteria.
摘要翻译：提供了一种通过经胸阻抗测量来确定肺功能的系统和方法。由可植入医疗器械收集的经胸阻抗测量与肺功能测量相关。肺功能测量按呼吸模式分组。评估肺功能。通过将每个呼吸模式的肺功能测量与至少一个之前的呼吸模式的肺功能测量进行比较来确定差异。从差异中确定出一个趋势。在趋势与阈值标准的充分偏差之后产生警报。

6. 发明授权

US08731666B2 Minimizing hemodynamic compromise during post-MI remodeling control pacing 有权
标题翻译：在MI后重建控制起搏中最大限度地减少血液动力学损害
公开(公告)号：US08731666B2
公开(公告)日：2014-05-20
申请号：US12819688
申请日：2010-06-21
申请人： Joseph M. Pastore , Rodney W. Salo , Jesse W. Hartley , Andrew P. Kramer , Jeffrey E. Stahmann
发明人： Joseph M. Pastore , Rodney W. Salo , Jesse W. Hartley , Andrew P. Kramer , Jeffrey E. Stahmann
IPC分类号： A61N1/368
CPC分类号： A61N1/3627 , A61N1/36521 , A61N1/3684
摘要： A method and device for delivering pre-excitation pacing to prevent or reduce cardiac remodeling following a myocardial infarction is described. The pre-excitation pacing is modulated in accordance with an assessment of cardiac function in order to balance the beneficial effects of stress reduction with hemodynamic compromise.
摘要翻译：描述了用于递送预激发起搏以预防或减少心肌梗塞后的心脏重塑的方法和装置。根据心脏功能的评估调节预激励起搏，以平衡应力减少与血液动力学妥协的有益效果。

7. 发明授权

US08655446B2 Cardiac pacing controlled via respiration therapy device 失效
标题翻译：通过呼吸治疗装置控制心脏起搏
公开(公告)号：US08655446B2
公开(公告)日：2014-02-18
申请号：US11986886
申请日：2007-11-27
申请人： Jeffrey E. Stahmann , Jesse W. Hartley , Kent Lee , Quan Ni
发明人： Jeffrey E. Stahmann , Jesse W. Hartley , Kent Lee , Quan Ni
IPC分类号： A61N1/365
CPC分类号： A61N1/3601 , A61N1/36514 , A61N1/36542 , A61N1/36578 , G06F19/00
摘要： Methods and systems involve adjusting cardiac pacing based on information acquired via a respiratory therapy device. A medical system includes a respiratory therapy device having one or more sensors and a therapy delivery unit. The one or more sensors are configured to sense respiration cycles. The therapy delivery unit is configured to deliver an external respiratory therapy to the patient. The medical system also includes a pulse generator configured to deliver cardiac pacing pulses to the patient. A controller is coupled to the one or more sensors and the pulse generator. The control unit configured to adjust a cardiac pacing rate based on the patient's respiration cycles.
摘要翻译：方法和系统涉及根据通过呼吸治疗装置获取的信息来调节心脏起搏。医疗系统包括具有一个或多个传感器和治疗递送单元的呼吸治疗装置。一个或多个传感器被配置成感测呼吸循环。治疗递送单元被配置为向患者输送外部呼吸治疗。医疗系统还包括脉冲发生器，其被配置为向患者传送心脏起搏脉冲。控制器耦合到一个或多个传感器和脉冲发生器。所述控制单元被配置为基于所述患者的呼吸周期来调节心脏起搏速率。

8. 发明授权

US08483818B2 Enhancements to the detection of pulmonary edema when using transthoracic impedance 有权
标题翻译：使用经胸阻抗检测肺水肿的增强
公开(公告)号：US08483818B2
公开(公告)日：2013-07-09
申请号：US13033081
申请日：2011-02-23
申请人： Jeffrey E. Stahmann , John D. Hatlestad , Jesse W. Hartley
发明人： Jeffrey E. Stahmann , John D. Hatlestad , Jesse W. Hartley
IPC分类号： A61B5/05 , A61B5/04 , A61N1/00
CPC分类号： A61B5/0537 , A61B5/0002 , A61B5/0538 , A61B5/4869 , A61B5/4878
摘要： This patent document discusses, among other things, systems, devices, and methods for enhancing detection of pulmonary edema using, in addition to thoracic impedance, one or a combination of: physiologic information about a subject, at least one statistical parameter, a user-programmable detection level, at least one parameter associated with a previous pulmonary edema event, and patient symptom information about the subject. In one example, a (base) thoracic impedance threshold is modified to an adjusted thoracic impedance threshold. The adjusted thoracic impedance threshold provides an increased sensitivity of pulmonary edema detection as compared to the base thoracic impedance threshold. In another example, an alert is provided to a subject, a caregiver, or other user based on a pulmonary edema indication determined by the present systems, devices, and methods. In a further example, a therapy (provided to the subject) is adjusted or initiated in response to the pulmonary edema indication.
摘要翻译：该专利文献尤其涉及用于增强肺水肿检测的系统，装置和方法，除胸部阻抗之外，还包括以下之一或组合：关于受试者的生理信息，至少一个统计参数，可编程检测水平，与先前的肺水肿事件相关联的至少一个参数，以及关于受试者的患者症状信息。在一个示例中，（基底）胸部阻抗阈值被修改为经调整的胸部阻抗阈值。与基础胸廓阻抗阈值相比，经调整的胸廓阻抗阈值提供了肺水肿检测的灵敏度增加。在另一示例中，基于由本系统，设备和方法确定的肺水肿指示，向受检者，照顾者或其他用户提供警报。在另一个实例中，响应于肺水肿指示调整或启动治疗（提供给受试者）。

9. 发明授权

US08064997B2 Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia 有权
标题翻译：用于治疗不规则心室收缩的方法和装置，例如在心房心律失常期间
公开(公告)号：US08064997B2
公开(公告)日：2011-11-22
申请号：US11423516
申请日：2006-06-12
申请人： David B. Krig , Jesse W. Hartley , Wyatt Stahl , Jeffrey E. Stahmann
发明人： David B. Krig , Jesse W. Hartley , Wyatt Stahl , Jeffrey E. Stahmann
IPC分类号： A61N1/362
CPC分类号： A61N1/3956 , A61N1/3622 , A61N1/395
摘要： A cardiac rhythm management system is capable of treating irregular ventricular heart contractions, such as during atrial tachyarrhythmias such as atrial fibrillation. A first indicated pacing interval is computed based at least partially on a most recent V-V interval duration between ventricular beats and a previous value of the first indicated pacing interval. Pacing therapy is provided based on either the first indicated pacing interval or also based on a second indicated pacing interval, such as a sensor-indicated pacing interval. A weighted averager such as an infinite impulse response (IIR) filter adjusts the first indicated pacing interval for sensed beats and differently adjusts the first indicated pacing interval for paced beats. The system regularizes ventricular rhythms by pacing the ventricle, but inhibits pacing when the ventricular rhythms are stable.
摘要翻译：心律管理系统能够治疗不规则的心室心脏收缩，例如在房性快速性心律失常如心房颤动期间。至少部分地基于心室搏动之间的最新V-V间期持续时间和第一个起搏间隔的先前值来计算第一个起搏间隔。基于第一个起搏间隔或基于第二个起搏间隔（例如传感器指示的起搏间隔）来提供起搏疗法。诸如无限脉冲响应（IIR）滤波器的加权平均器调节感测节拍的第一个起搏间隔，并且针对起搏节奏不同地调节第一个起搏间隔。系统通过起搏心室使心室节律正常化，但是当心室节律稳定时，可抑制起搏。

10. 发明申请

US20100256702A1 MINIMIZING HEMODYNAMIC COMPROMISE DURING POST-MI REMODELING CONTROL PACING 有权
标题翻译：在心肌梗死后重建控制中最小化血液动力学压力
公开(公告)号：US20100256702A1
公开(公告)日：2010-10-07
申请号：US12819688
申请日：2010-06-21
申请人： Joseph M. Pastore , Rodney W. Salo , Jesse W. Hartley , Andrew P. Kramer , Jeffrey E. Stahmann
发明人： Joseph M. Pastore , Rodney W. Salo , Jesse W. Hartley , Andrew P. Kramer , Jeffrey E. Stahmann
IPC分类号： A61N1/368
CPC分类号： A61N1/3627 , A61N1/36521 , A61N1/3684
摘要： A method and device for delivering pre-excitation pacing to prevent or reduce cardiac remodeling following a myocardial infarction is described. The pre-excitation pacing is modulated in accordance with an assessment of cardiac function in order to balance the beneficial effects of stress reduction with hemodynamic compromise.
摘要翻译：描述了用于递送预激发起搏以预防或减少心肌梗塞后的心脏重塑的方法和装置。根据心脏功能的评估调节预激励起搏，以平衡应力减少与血液动力学妥协的有益效果。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式